Fidelity International
AXSM icon

Fidelity International’s Axsome Therapeutics AXSM Stock Holding History

Fidelity International’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,176
Closed -$686K – 829
2021
Q2 		$686K Hold
10,176
– – ﹤0.01% 768
2021
Q1 		$576K Buy
10,176
+10,101
+13,468% +$711K ﹤0.01% 762
2020
Q4 		$6K Hold
75
– – ﹤0.01% 817
2020
Q3 		$5K Buy
75
+40
+114% +$3.12K ﹤0.01% 781
2020
Q2 		$3K Sell
35
-265,050
-100% -$20.4M ﹤0.01% 790
2020
Q1 		$15.6M Buy
265,085
+65,934
+33% +$5.37M 0.03% 390
2019
Q4 		$20.6M Sell
199,151
-11,102
-5% -$448K 0.03% 402
2019
Q3 		$4.26M Buy
+210,253
New +$5.4M 0.01% 564

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fidelity International's AXSM Position: Q3 2021 in Review

Fidelity International sold out of Axsome Therapeutics (AXSM) in Q3 2021, closing a stake of 10,176 shares — an estimated $686K sold.

Fidelity International first reported a position in AXSM in Q3 2019 and held it in 8 quarters. The position peaked at $20.6M in Q4 2019. 171 funds tracked by Wall St. Rank hold AXSM as of Q3 2021.

  • Fidelity International reported no remaining Axsome Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Fidelity International sold 10,176 Axsome Therapeutics shares in Q3 2021, an estimated $686K.
  • Fidelity International first reported a position in Axsome Therapeutics in Q3 2019 and held it in 8 quarters.
  • Fidelity International's Axsome Therapeutics position peaked at $20.6M in Q4 2019.
  • 171 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2021.

Based on Fidelity International's 13F filing for Q3 2021, filed 15 Nov 2021.